Next Article in Journal
Regulators of G-Protein Signaling (RGS) in Sporadic and Colitis-Associated Colorectal Cancer
Next Article in Special Issue
Beneficial Effects of Probiotic Lactobacillus paraplantarum BGCG11 on Pancreatic and Duodenum Function in Diabetic Rats
Previous Article in Journal
Traces of Canine Inflammatory Bowel Disease Reflected by Intestinal Organoids
Previous Article in Special Issue
Intestinal Microbiotas and Alcoholic Hepatitis: Pathogenesis and Therapeutic Value
 
 
Article
Peer-Review Record

Lactiplantibacillus plantarum HY7718 Improves Intestinal Integrity in a DSS-Induced Ulcerative Colitis Mouse Model by Suppressing Inflammation through Modulation of the Gut Microbiota

Int. J. Mol. Sci. 2024, 25(1), 575; https://doi.org/10.3390/ijms25010575
by Hyeon-Ji Kim, Hye-Jin Jeon, Joo-Yun Kim *, Jae-Jung Shim and Jae-Hwan Lee
Reviewer 1: Anonymous
Reviewer 2: Anonymous
Int. J. Mol. Sci. 2024, 25(1), 575; https://doi.org/10.3390/ijms25010575
Submission received: 13 December 2023 / Revised: 27 December 2023 / Accepted: 29 December 2023 / Published: 1 January 2024

Round 1

Reviewer 1 Report

Comments and Suggestions for Authors


Comments for author File: Comments.pdf

Author Response

Please see the attachment.

Author Response File: Author Response.pdf

Reviewer 2 Report

Comments and Suggestions for Authors

The current study investigates the impact of a novel probiotic in treating colitis in mice. The study is thoroughly conducted and of a very high standard. The findings are significant and demonstrate the potential for the probiotic to treat colitis / IBD by reducing pro-inflammatory responses and positively modulating the gut microbiome. I recommend publication after the following minor corrections:

1. The authors should report the animal study based on ARRIVE guidelines, in particularly the Essential 10. It would be of interest to know whether the animals were randomized and whether the handling / research team were blinded to various treatment groups.

2. Statistical singificance is reported against control groups in most figures, but it would be good to demonstrate statistical significance across each treatment group. E.g. does ATCC149177 suppress the expression of pro-inflammatory cytokines to a greater degree than SULF?

Author Response

Please see the attachment.

Author Response File: Author Response.pdf

Back to TopTop